NCT05849961 is a clinical trial of Exactech Hip Systems in Hip Arthroplasty, Total, sponsored by Exactech.

Who is sponsoring NCT05849961?

NCT05849961 is sponsored by Exactech.

What drugs are being tested in NCT05849961?

Interventions in NCT05849961: Exactech Hip Systems.

What condition does NCT05849961 study?

NCT05849961 studies Hip Arthroplasty, Total.

Is NCT05849961 still recruiting?

NCT05849961 is currently recruiting now. Last updated 18 June 2024.

Last reviewed 2024-06-18 · How we verify

NCT05849961

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Exactech Hip Systems Post-Market Clinical Follow-up (PMCF)

Recruiting now Last updated 18 June 2024

What this trial tests

trial testing Exactech Hip Systems in Hip Arthroplasty, Total in 2,946 participants. Currently enrolling.

Timeline

13 October 2023

Primary endpoint
31 July 2036

31 December 2036

Quick facts

Lead sponsor	Exactech
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	2,946
Start date	13 October 2023
Primary completion	31 July 2036
Estimated completion	31 December 2036
Sites	1 location across United States

Drugs / interventions tested

Exactech Hip Systems

Conditions studied

Hip Arthroplasty, Total — all drugs for Hip Arthroplasty, Total →

Sponsor

Exactech

Who can join

18 and older, any sex, with Hip Arthroplasty, Total. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A Post-Market Domestic (US) and International Data Collection to Assess Exactech Hip Systems

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hip Arthroplasty, Total

Currently open trials in the same condition.

NCT07263932 — PENG vs PHPB for Hip Arthroplasty Analgesia · recruiting
NCT06982625 — Supra Inguinal Fascia Iliaca Block as Rescue Analgesia Following Total Hip Arthroplasty · NA · recruiting
NCT06971757 — HAKA: Routine Follow-Up at 1 Year After Hip- or Knee Arthroplasty: Wasting Resources or Appropriate Healthcare? · NA · recruiting
NCT06780319 — Digital Rehabilitation After Hip Arthroplasty: a Randomized Controlled Trial · NA · recruiting
NCT06803914 — Analysis of Biomechanical Parameters and Return to Sport After Total Hip Replacement · recruiting

Other Exactech trials

Trials by the same sponsor.

NCT05703958 — Exactech Proximal Humerus Fracture Plate System Post Market Clinical Follow-up · recruiting
NCT05615259 — Comparison Between Exactech Guided Personalized Surgery (GPS) and Conventional Instrumentation of Shoulder Arthroplasty · recruiting
NCT05691868 — Vantage Mobile Bearing Total Ankle System Post Market Clinical Follow-up (Outside US) · recruiting
NCT05653102 — A Post-Market Domestic (US) and International Data Collection to Assess the Truliant Knee System · recruiting
NCT05615246 — Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP) · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05849961 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Exactech
Last refreshed: 18 June 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05849961.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing